Noronex Ltd. (AU:NRX) has released an update.
Noronex Limited has reported a change in director David Prentice’s interests, with an acquisition of over 1.5 million unquoted options and over 1.1 million fully paid ordinary shares, reflecting his increased stake in the company. The securities were obtained through participation in a placement and the grant of incentive options, with some obtained at no cost and others for a total consideration of $9,533.33. The director now holds a significantly larger share, with multiple classes of options and ordinary shares in his portfolio.
For further insights into AU:NRX stock, check out TipRanks’ Stock Analysis page.
